Challenges in diagnosis and management of a spiradenocarcinoma: a comprehensive literature review
Autor: | Ee Jun Ban, James Cheng Yen Lee, Rhoda Cameron, Jonathan W. Serpell, Karishma Jassal, Katy Wagner |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Skin Neoplasms Spiradenocarcinoma medicine.medical_treatment Metastasis 03 medical and health sciences 0302 clinical medicine medicine Humans Lymph node Aged Skin Neoplasm medicine.diagnostic_test business.industry Wide local excision General Medicine medicine.disease Sweat Gland Neoplasms Dissection medicine.anatomical_structure Lymphatic Metastasis 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Surgery Lymph Nodes Radiology Neoplasm Recurrence Local Spiradenoma business Liver function tests |
Zdroj: | ANZ Journal of Surgery. 91:1996-2001 |
ISSN: | 1445-2197 1445-1433 |
Popis: | Background Spiradenocarcinoma is a rare skin adnexal neoplasm that may behave aggressively. It is often associated with a benign slow-growing spiradenoma that has undergone malignant transformation. Given the paucity of cases in the literature, there is a lack of consensus on treatment. Methods The terms 'malignant spiradenoma' or 'spiradenocarcinoma' were systematically used to search the PubMed, MEDLINE and Google Scholar databases. A total of 182 cases of spiradenocarcinoma were identified as eligible for this comprehensive literature review. Results Spiradenocarcinoma was commoner in older age and Caucasian race. In most cases, surgical excision for local disease is the mainstay of treatment. Lymph node dissection is usually reserved for those with suspected or confirmed lymph node metastases. High rates of local recurrence (20.8%), metastasis (37.4%) and mortality (19.1%) were identified, prompting some authors to suggest regular follow up including chest X-rays and liver function tests. Conclusions Patients with spiradenocarcinoma may benefit from a magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography/computed tomography to establish the extent of disease. We recommend wide local excision as the treatment of choice to achieve surgical margins of ≥1 cm, with node resection to be determined on a case-to-case basis. Regular follow up is important given the high rate of local recurrence, metastasis and mortality. This should include an examination of the regional lymph nodes. Further research is required to refine an evidence-based approach to spiradenocarcinoma. |
Databáze: | OpenAIRE |
Externí odkaz: |